Get the Stockscreener App
45.68
2.50%
-1.17
Pre-market:
45.03
-0.65
-1.42%
Qiagen Nv stock is traded at $45.68, with a volume of 1.71M.
It is down -2.50% in the last 24 hours and down -2.39% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$46.85
Open:
$46.28
24h Volume:
1.71M
Relative Volume:
1.44
Market Cap:
$10.16B
Revenue:
$2.04B
Net Income/Loss:
$373.39M
P/E Ratio:
26.93
EPS:
1.6961
Net Cash Flow:
$495.96M
1W Performance:
-5.62%
1M Performance:
-2.39%
6M Performance:
+5.91%
1Y Performance:
+3.09%
1-Day Range:
$45.31
$46.32
1-Week Range:
$45.31
$48.63
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
45.68 | 10.16B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
How Qiagen N.V. Common Shares stock performs in easing cyclesWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Why Qiagen N.V. (QIA) stock is listed among top recommendationsRate Cut & Expert Curated Trade Setup Alerts - newser.com
Full technical analysis of Qiagen N.V. stockWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Can Qiagen N.V. stock hit record highs again2025 Market Overview & Weekly High Return Opportunities - newser.com
Will Qiagen N.V. see short term momentumJuly 2025 Review & Weekly Breakout Watchlists - newser.com
What momentum shifts mean for Qiagen N.V.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of E - GuruFocus
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
What downside risks could hit Qiagen N.V. Common Shares stockJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Is Qiagen N.V. stock supported by strong fundamentals2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Using portfolio simulators with Qiagen N.V. includedJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Can Qiagen N.V. stock sustain free cash flow growth2025 Momentum Check & Expert Curated Trade Ideas - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsStock Surge & Scalable Portfolio Growth Ideas - newser.com
What earnings revisions data tells us about Qiagen N.V.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com
Is Qiagen N.V. stock cheap compared to fundamentals2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Momentum divergence signals in Qiagen N.V. chartMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Qiagen (NYSE:QGEN) Valuation in Focus as Forensic Automation and Lab Milestones Drive Future Growth Prospects - simplywall.st
Will Qiagen N.V. (QIA) stock beat Nasdaq index returnsWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com
QIAGEN launches new automated sexual assault sample processing kit - SelectScience
How to integrate Qiagen N.V. into portfolio analysis toolsVolume Spike & Weekly Watchlist of Top Performers - newser.com
Is Qiagen N.V. stock a safe haven assetJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - newser.com
What to expect from Qiagen N.V. in the next 30 daysJuly 2025 Catalysts & Weekly High Momentum Picks - newser.com
Why retail investors favor Qiagen N.V. stockGap Down & Entry and Exit Point Strategies - newser.com
Will Qiagen N.V. Common Shares stock sustain dividend payoutsWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Regression analysis insights on Qiagen N.V. performanceLong Setup & Risk Controlled Daily Trade Plans - newser.com
Volume spikes in Qiagen N.V. stock – what they meanPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Is Qiagen N.V. (QIA) stock ideal for retirement investorsWeekly Trade Recap & High Accuracy Trade Alerts - newser.com
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase - ADVFN
Will Qiagen's (QGEN) Automation Push Redefine Its Edge in Forensic Lab Innovation? - simplywall.st
Will Qiagen N.V. (QIA) stock keep high P E multiplesMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Qiagen NV expected to post earnings of 59 cents a shareEarnings Preview - TradingView
QIAGEN launches automated sexual assault sample processing kit By Investing.com - Investing.com Australia
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):